Health Trials

Stage II Lung Cancer

3

Review clinical trials related to Stage II Lung Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Avecure Flexible Microwave Ablation Probe For Lung Nodules

This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)

Participants needed: 10
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Beth Israel Deaconess Medical CenterUpdated: Apr 8, 2026Locations: 1
Eligibility criteria

Subject with Stage I - II primary lung cancer (Solitary nodules up to 3 cm) as d... [+4]

Subjects in whom flexible bronchoscopy is contraindicated [+9]

Read more
Status: Not yet recruiting

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

The purpose of this study is to test the feasibility of the Precise Exercise Regimen for Cancer Care (PERCC) exercise program in participants with stage II-III primary lung cancer.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: Feb 17, 2026
Eligibility criteria

Age ≥18 years at time of diagnosis; due to the rarity of the disease in those <1... [+5]

Patients who are morbidly obese (BMI>40 kg/m2) or Anorexic (BMI<17 kg/m2). [+5]

Read more
Status: Recruiting

Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

This clinical trial studies side effects and best treatment time of cryodevitalization in treating patients with early stage (stage I or stage II) lung cancer. Cryodevitalization is a type of cryosurgery that uses a flexible probe (cryoprobe) to kill tumor cells by freezing them. It is delivered at the time of standard diagnostic robotic bronchoscopy. Using cryodevitalization may be safe, tolerable and/or effective in treating patients with early stage lung cancer.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Vanderbilt-Ingram Cancer CenterUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Patients with a single pulmonary nodule with a size less than or equal to three... [+3]

Target nodule is within the International Association for the Study of Lung Canc... [+8]

Read more